The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen

Blood. 1994 Sep 1;84(5):1402-7.

Abstract

T-cell activation is initiated after T-cell receptor binding to antigen, but also requires interactions between costimulatory molecules expressed on antigen-presenting cells. An important costimulatory molecule expressed by monocytes and activated B lymphocytes has been recently identified and termed B7-2 or B70. Independently, a new Cluster of Differentiation was defined in the Fifth International Leukocyte Differentiation Antigen Workshop as CD86, a molecule predominantly expressed by monocytes and activated B lymphocytes. In this study, the two monoclonal antibodies that defined CD86, FUN-1 and BU-63, were shown to bind to cDNA transfected cells expressing B7-2/B70. The FUN-1 monoclonal antibody also completely blocked the costimulatory activity of B7-2/B70 in functional assays. Therefore, the serologically defined CD86 differentiation antigen is the B7-2/B70 molecule.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Antigens, CD*
  • B-Lymphocytes / immunology*
  • B7-1 Antigen / analysis
  • B7-1 Antigen / biosynthesis*
  • B7-1 Antigen / blood
  • B7-2 Antigen
  • CHO Cells
  • Cell Division / drug effects
  • Cricetinae
  • Epitopes / analysis
  • Fluorescent Antibody Technique
  • Gene Expression / drug effects
  • Humans
  • Immunoglobulin G
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation
  • Membrane Glycoproteins*
  • Muromonab-CD3 / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thymidine / metabolism
  • Transfection

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • B7-1 Antigen
  • B7-2 Antigen
  • CD86 protein, human
  • Epitopes
  • Immunoglobulin G
  • Membrane Glycoproteins
  • Muromonab-CD3
  • Tetradecanoylphorbol Acetate
  • Thymidine